Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-01-28 1:39 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Frazier Life Sciences Public Fund L.P. | 1,505,200 6.9% | 200,000 (+15.32%) | View |
2021-10-27 6:12 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Avidity Partners Management LP | 1,120,925 6.6% | 1,120,925 (New Position) | View |
2021-10-14 4:05 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Venrock Healthcare Capital Partners III L.P. | 1,943,055 9.99% | 1,943,055 (New Position) | View |
2021-10-08 08:36 am Sale | 13G | VIRIDIAN THERAPEUTICS INC VRDN | WELLINGTON MANAGEMENT GROUP LLP | 0 0% | -578,560 (Position Closed) | View |
2021-09-30 4:30 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Vivo Opportunity LLC | 1,300,000 7.7% | 1,300,000 (New Position) | View |
2021-09-29 09:30 am Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Logos Global Management LP | 1,495,000 8.8% | 1,495,000 (New Position) | View |
2021-09-29 06:02 am Unchanged | 13G | VIRIDIAN THERAPEUTICS INC VRDN | TCG Crossover Management LLC | 1,314,000 8.2% | 0 (Unchanged) | View |
2021-09-24 5:01 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Deep Track Capital LP | 1,819,689 9.9% | 1,819,689 (New Position) | View |
2021-09-24 1:59 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | TCG Crossover Management LLC | 1,314,000 13.7% | 400,000 (+43.76%) | View |
2021-09-23 4:31 pm Purchase | 13D | VIRIDIAN THERAPEUTICS INC VRDN | Fairmount Funds Management LLC | 3,460,351 19.99% | 3,460,351 (New Position) | View |
2021-09-10 06:03 am Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | TCG Crossover Management LLC | 914,000 9.5% | 914,000 (New Position) | View |
2021-08-26 12:56 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Frazier Life Sciences Public Fund L.P. | 1,305,200 13.6% | 1,305,200 (New Position) | View |
2021-06-01 4:02 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | D. E. SHAW & CO L.P. | 720,373 8.5% | 248,679 (+52.72%) | View |
2021-05-10 4:04 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | D. E. SHAW & CO L.P. | 471,694 6.5% | 471,694 (New Position) | View |
2021-03-15 4:38 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | RA CAPITAL MANAGEMENT L.P. | 388,385 6.3% | 388,385 (New Position) | View |
2021-03-10 07:17 am Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | WELLINGTON MANAGEMENT GROUP LLP | 578,560 11.1% | 578,560 (New Position) | View |
2021-02-19 08:02 am Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Hawkes Bay Master Investors (Cayman) L.P. | 363,284 6.97% | 363,284 (New Position) | View |
2021-02-16 4:30 pm Purchase | 13G | MIRAGEN THERAPEUTICS INC MGEN | CITADEL ADVISORS LLC | 427,218 9.9% | 656 (+0.15%) | View |
2021-02-16 3:09 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Point72 Asset Management L.P. | 426,162 10.9% | 426,162 (New Position) | View |
2021-01-19 4:18 pm Purchase | 13G | MIRAGEN THERAPEUTICS INC MGEN | Cormorant Asset Management LP | 459,144 9.99% | 459,144 (New Position) | View |